Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch Biographer
Diabetes Mellitus, Insulin-Dependent
About this trial
This is an interventional treatment trial for Diabetes Mellitus, Insulin-Dependent focused on measuring Diabetes Mellitus, Insulin-Dependent, Type 1 Diabetes, Diabetes in Children, Continuous Glucose Monitoring Devices
Eligibility Criteria
Inclusion Criteria Clinical diagnosis of type 1 diabetes Insulin therapy (either a pump or at least 2 injections per day) for at least one year prior to study entry HbA1c between 7.0 and 11.0% Stable insulin regimen for the 2 months prior to study entry and no plans to switch the modality of insulin administration during the next 6 months (e.g., injection user switching to a pump, pump user switching to injections, or the addition of Lantus [Glargine] insulin) Agree to comply with study requirements, including the performance of at least 4 fingerstick glucose checks a day using a home glucose monitor Comprehend written English Female participants must not intend to become pregnant during the next 6 months Plan to remain in the area of the clinical center during the next 6 months
Sites / Locations
- Division of Pediatric Endocrinology and Diabetes, Stanford University
- Barbara Davis Center for Childhood Diabetes, University of Colorado
- Department of Pediatrics, Yale University School of Medicine
- Nemours Children's Clinic
- Jaeb Center for Health Research
- Department of Pediatrics, University of Iowa Carver College of Medicine